Implant Centre Martinko has been acquired by Adria Dental Group
October 2024 — Adria Dental Group (ADG) has acquired Implant Centre Martinko (ICM) from a private individual who was also its head surgeon. This investment represents a significant strategic move for ADG, marking its entry into the Italian market, strengthening its position in Croatia and opening new opportunities for growth. Both entities will see improvements in patient care quality through this collaboration, and ICM employees will benefit from enhanced working conditions.
ICM is a renowned Croatian dental implant center, with a clinic in Zagreb and two clinics in Milan and Trieste, Italy. It offers a range of services, including dental implantology, prosthetics and conservative and aesthetic dentistry. The company is a pioneer in positioning Croatia as a destination for high-quality dental services in the EU market and beyond.
Adria Dental Group is the largest dental group in the Adriatic region, operating 12 clinics across Croatia and Slovenia, over 150 cutting-edge dental offices and nine high-end laboratories. The group employs over 700 professionals and treats nearly 55,000 patients annually.
Provectus Capital Partners (PCP) is a private equity firm operating in Southeast Europe, with a primary focus on investments in healthcare companies across Croatia and neighboring countries such as Slovenia.
Our role in the transaction
Oaklins’ team in Croatia was mandated as the sell-side advisor to the seller.
Talk to the deal team
Related deals
Katalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Learn moreLife & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
Learn moreRöntgeninstitut Aarau has been acquired by Evidia
The owners of Röntgeninstitut Aarau have sold the business to Evidia Group as part of their succession planning. The former owners will remain involved in the institute and support its future development alongside Evidia.
Learn more